BOTOX® Economic Spasticity Trial (BEST)

Status Completed

Clinical Trial Summary

This is a study to investigate if patients who have had a stroke and suffer from spasticity might benefit from being given BOTOX® in addition to the normal Standard Care. Spasticity is characterized by stiffness or frequent cramps accompanied by pain and abnormal movements and can prevent the carrying out of everyday tasks such as walking and getting dressed. BOTOX® is a neurotoxin, which is used to prevent the contraction of muscle fibre and has been shown to reduce spasticity significantly. Patients will be enrolled in this study at about 33 locations in Europe and Canada. Study participation will last for about 1 year.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Muscle Spasticity

Clinical Trial Details

NCT number	NCT00549783
Study type	Interventional
Source	Allergan
Contact
Status	Completed
Phase	Phase 4
Start date	October 2007
Completion date	July 2010

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT04535479` - Dry Needling for Spasticity in Stroke	N/A
Completed	`NCT02907775` - Multi-channel Stimulation for Post Stroke Spasticity (MUSTS)	N/A
Recruiting	`NCT04530955` - Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS)	N/A
Active, not recruiting	`NCT03521076` - Randomized Controlled Trial of Virtual Reality	N/A
Completed	`NCT03080454` - The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke	Phase 1/Phase 2
Completed	`NCT02546999` - Does Botulinum Toxin A Make Walking Easier in Children With Cerebral Palsy?	Phase 4
Active, not recruiting	`NCT01041157` - Botulinum Toxin Injection Efficiency	Phase 1
Completed	`NCT00535938` - MDs on Botox Utility (MOBILITY)	N/A
Terminated	`NCT00532532` - Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis	Phase 2
Terminated	`NCT00531466` - Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury	Phase 2
Completed	`NCT05546190` - A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)
Recruiting	`NCT06117020` - Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals	Phase 1
Completed	`NCT01603628` - BOTOX® Treatment in Pediatric Lower Limb Spasticity	Phase 3
Completed	`NCT05510726` - Quantitative Evaluation of Muscle Stiffness in Neurological Patients With Muscle Overactivity
Not yet recruiting	`NCT04378946` - Error Augmentation Motor Learning Training Approach in Stroke Patients	N/A
Completed	`NCT01603615` - BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity	Phase 3
Completed	`NCT01251380` - Dysport® Pediatric Lower Limb Spasticity Follow-on Study	Phase 3
Completed	`NCT00210431` - Post Marketing Surveillance Study of Dysport
Completed	`NCT00076687` - Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function	Phase 2
Completed	`NCT04543448` - Effect of Cervical Mobilization on Balance and Plantar Pressure Distribution in Multiple Sclerosis	N/A